As a result of the discovery of the nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK) fusion receptor tyrosine kinase in a subgroup of patients, this illness is now classified by the World Health Organization as either ALCL that is ALK-positive or -negative. Here, NPM1 is linked to anaplastic large cell lymphoma.